Venlo, 1 August 2025

Today we announce the strengthening of our team with the appointment of Dr. Sander Kok as Chief Operating Officer. After obtaining his PhD in analytical chemistry at the University of Amsterdam, Sander held positions with increasing scope and responsibility in companies in various sectors. His broad analytical knowledge, ranging from foods to polymers and from pharmaceutical drug substances to medicines, makes him the ideal person to lead our operational activities.

Our CEO, Dr. Marcel Langoor, said: “I had the pleasure of working with Sander during a consultancy assignment at a CDMO for small molecules and was impressed by the way he leads his team and his in-depth knowledge of analytical chemistry in a broad sense. I am confident that he will take the team to the next level, enabling us to grow faster.”

Commenting on his appointment, Sander said: “I am excited to join Brightlabs and contribute to the further growth and expansion of the company. Together with the fantastic team, we will continue the journey of building a great company that CTO Bart Kuijpers started 10 years ago. I look forward to a successful collaboration with the team, our partners, and our customers!”

For further information please send an e-mail to contact@brightlabs.nl.